Brad Kahl

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

Bruce D Cheson, R. Advani, J. Winter, 2014, Journal of Hematology & Oncology.

Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--patient studies.

Eric C Frey, George Sgouros, Yong Du, 2009, Medical physics.